Bayesian Capital Management, LP Johnson & Johnson Transaction History

Bayesian Capital Management, LP

$854 Million
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$155.22 - $162.74 $3.21 Million - $3.37 Million	20,700 New	20,700 $3.27 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $5.25 Million - $5.88 Million	33,680 Added 191.15%	51,300 $7.99 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $2.52 Million - $2.71 Million	-16,341 Reduced 48.12%	17,620 $2.92 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $5.13 Million - $6.12 Million	33,961 New	33,961 $5.26 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $237,961 - $264,792	-1,475 Reduced 31.43%	3,218 $526,000
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $388,014 - $429,125	-2,307 Reduced 32.96%	4,693 $833,000
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $879,890 - $999,238	5,564 Added 387.47%	7,000 $1.24 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $223,915 - $248,442	1,436 New	1,436 $246,000
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $1.9 Million - $2.11 Million	-11,767 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$159.48 - $171.07 $1.88 Million - $2.01 Million	11,767 New	11,767 $1.94 Million
Q1 2021 May 14, 2021	SELL	$153.07 - $170.48 $4.91 Million - $5.47 Million	-32,100 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $4.4 Million - $5.05 Million	32,100 New	32,100 $5.05 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $268,847 - $372,501	-2,419 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $660,577 - $758,705	-5,181 Reduced 68.17%	2,419 $353,000
Q3 2019 Nov 13, 2019	BUY	$126.95 - $142.14 $964,820 - $1.08 Million	7,600 New	7,600 $983,000
Q1 2019 May 14, 2019	SELL	$125.72 - $139.79 $1.1 Million - $1.23 Million	-8,764 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$122.84 - $147.84 $2.26 Million - $2.73 Million	-18,436 Reduced 67.78%	8,764 $1.13 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $3.31 Million - $3.89 Million	27,200 New	27,200 $3.76 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $2.35 Million - $2.79 Million	-18,800 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$131.22 - $143.62 $183,708 - $201,068	-1,400 Reduced 6.93%	18,800 $2.63 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $2.62 Million - $2.73 Million	20,200	20,200 $2.63 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Account